BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 30-Apr-2019

(Q3 Un-audited): EPS was Tk. 4.15 for January-March 2019 as against Tk. 4.29 for January-March 2018; EPS was Tk. 13.46 for July 2018-March 2019 as against Tk. 12.34 for July 2017-March 2018. NOCFPS was Tk. 7.82 for July 2018-March 2019 as against Tk. 1.98 for July 2017-March 2018. NAV per share was Tk. 69.11 as on March 31, 2019 and Tk. 60.81 as on June 30, 2018.

PHARMAID 24-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

PHARMAID 05-Feb-2019

The Company has informed that it has disbursed the cash dividend to the respective shareholders for the year ended on June 30, 2018.

PHARMAID 31-Jan-2019

(Q2 Un-audited): EPS was Tk. 4.67 for October-December 2018 as against Tk. 4.26 for October-December 2017; EPS was Tk. 9.31 for July-December 2018 as against Tk. 8.05 for July-December 2017. NOCFPS was Tk. 11.00 for July-December 2018 as against Tk. 3.35 for July-December 2017. NAV per share was Tk. 65.02 as on December 31, 2018 and Tk. 60.81 as on June 30, 2018.

PHARMAID 24-Jan-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2019 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2018.

PHARMAID 26-Dec-2018

National Credit Ratings Limited (NCR) has announced the Surveillance Rating of the Company as "A" in the long term and "ST-3" in the short term along with a stable outlook based on audited financial statements of the Company of June 30, 2018.

PHARMAID 02-Dec-2018

Trading of the shares of the Company will resume on 03.12.2018 after record date.

PHARMAID 29-Nov-2018

Trading of the shares of the Company will remain suspended on record date i.e., 02.12.2018.

PHARMAID 27-Nov-2018

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 28.11.2018 to 29.11.2018. Trading of the shares of the Company will remain suspended on record date i.e., 02.12.2018.

PHARMAID 15-Nov-2018

(Q1 Un-audited): EPS was Tk. 4.63 for July-September, 2018 as against Tk. 3.80 for July-September, 2017; NOCFPS was Tk. 6.06 for July-September, 2018 as against Tk. 1.89 for July-September, 2017. NAV per share was Tk. 65.40 as on September 30, 2018 and Tk. 60.81 as on June 30, 2018.

Previous Next page